An intragastric balloon in the treatment of obese individuals with metabolic syndrome: A randomized controlled study
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Objective: There are limited controlled data for intragastric balloons (IGB) in obesity treatment. This randomized, controlled study evaluated the efficacy and safety of an IGB in obese individuals with metabolic syndrome (MS). Design and Methods: Sixty‐six adults (BMI: 30‐40 kg/m 2) were randomized to IGB for 6 months, with a 12 month behavioral modification (IGB Group; “IGBG”), or 12 month behavioral modification alone (Control Group; “CG”). The primary outcome was percentage change in body weight. Results: Thirty‐one subjects (female: 68%; mean age: 43; mean BMI: 36.0) were randomized to IGBG and 35 (66%; 48; 36.7) to CG. At 6 months, there was a significantly greater weight loss in the IGBG: −14.2 vs. −4.8; P < 0.0001. This was associated with a significantly greater reduction in waist circumference, and an improvement in quality of life, with a trend for a larger %MS remission (50% vs. 30%; n.s.). At month 12, the differences in weight loss were enduring: −9.2 vs. −5.2; P = 0.007. Gastrointestinal‐related adverse events were common in the IGBG, resolving predominantly within two weeks. The IGB was removed prematurely in three subjects (one for refractory gastrointestinal symptoms). Conclusions: Statistically significant and clinically relevant improvements in weight loss and health outcomes were observed with the IGBG at 6 months versus behavioral modification alone. The differential weight loss was still evident 6 months after IGB removal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 2×
“The same behavioral modification program was employed for both groups, based on the Type 2 Diabetes Lifestyle Intervention Program (26).”
MethodDiabetes Prevention Program Research Group (2009) · The Lancet · doi:10.1016/s0140-6736(09)61457-4 · Cited by 3,020 · cited 1×
“This so-called ‘‘metabolic memory effect’’ has also been shown previously in Diabetes Treatment and Prevention Outcome Studies (33,38) and it could be anticipated that such metabolic benefit would occur with the weight loss achieved in our trial.”
BackgroundLindström, J., Ilanne-Parikka, P., Peltonen, M., Aunola, S., Eriksson, J. G., Hemiö, K., Hämäläinen, H., Härkönen, P., Keinänen-Kiukaanniemi, S., Laakso, M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69701-8 · Cited by 1,799 · cited 2×
“This so-called ‘‘metabolic memory effect’’ has also been shown previously in Diabetes Treatment and Prevention Outcome Studies (33,38) and it could be anticipated that such metabolic benefit would occur with the weight loss achieved in our trial.”
BackgroundLong-term persistence of hormonal adaptations to weight loss
Sumithran, P., Prendergast, L. A., Delbridge, E., Purcell, K., Shulkes, A., Kriketos, A., & Proietto, J. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105816 · Cited by 1,449 · cited 3×
“The assumed loss of the premature satiation following the removal of the IGB does predict some weight regain, perhaps related to a significant physiologically derived defense of fat stores which is believed to exist in obese individuals (8).”
BackgroundInfluentialLong term pharmacotherapy for obesity and overweight: updated meta-analysis
Rucker, D., Padwal, R., Li, S. K., Curioni, C., & Lau, D. C. W. (2007) · BMJ · doi:10.1136/bmj.39385.413113.25 · Cited by 801
Meta-Analysis: Pharmacologic Treatment of Obesity
Li, Z., Maglione, M., Tu, W., Mojica, W., Arterburn, D., Shugarman, L. R., Hilton, L., Suttorp, M., Solomon, V., Shekelle, P. G., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-7-200504050-00012 · Cited by 774
Development of a brief measure to assess quality of life in obesity
Kolotkin, R. L., Crosby, R. D., Kosloski, K. D., & Williams, G. R. (2001) · Obesity Research · doi:10.1038/oby.2001.13 · Cited by 641
Cappelleri, J. C., Bushmakin, A. G., Gerber, R. A., Leidy, N. K., Sexton, C. C., Lowe, M. R., & Karlsson, J. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.74 · Cited by 467 · cited 4×
“26 (83.9) 26 (74.3) Weight (kg) 104.6 (14.8) 103.4 (13.9) BMI (kg/m2) 36.0 (2.7) 36.7 (2.9) BMI years > 30 kg/m2 7.4 (4.0) 8.3 (5.5) Waist circumference (cm) 115.4 (10.9) 115.2 (8.8) Systolic blood pressure (mmHg) 133.7 (10.1) 129.6 (13.2) Diastolic blood pressure (mmHg) 86.0 (6.3) 83.0 (7.3) Fasting blood glucose (mm…”
MethodInfluentialMeta-analysis: The Effect of Dietary Counseling for Weight Loss
Dansinger, M. L., Tatsioni, A., Wong, J. B., Chung, M., & Balk, E. M. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-1-200707030-00007 · Cited by 467 · cited 2×
“In clinical studies published to date, treatment protocols based on hypo-caloric intake and exercise alone commonly achieve a moderate weight reduction of approximately 5%, which is generally not maintained (5).”
BackgroundBioenterics intragastric balloon: the Italian experience with 2,515 patients
Genco, A., Bruni, T., Doldi, S. B., Forestieri, P., Marino, M., Busetto, L., Giardiello, C., Angrisani, L., Pecchioli, L., Stornelli, P., et al. (2005) · Obesity Surgery · doi:10.1381/0960892055002202 · Cited by 361 · cited 1×
“The majority of these studies have been uncontrolled and/or retrospective (13-20).”
BackgroundEffect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin
Miles, J. M., Leiter, L., Hollander, P., Wadden, T., Anderson, J. W., Doyle, M., Foreyt, J., Aronne, L., & Klein, S. (2002) · Diabetes Care · doi:10.2337/diacare.25.7.1123 · Cited by 286
Cited by
Abu Dayyeh, B. K., Kumar, N., Edmundowicz, S. A., Jonnalagadda, S., Larsen, M., Sullivan, S., Thompson, C. C., & Banerjee, S. (2015) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2015.03.1964 · Cited by 469
Intragastric balloon as an adjunct to lifestyle intervention: a randomized controlled trial.
Courcoulas, A., Abu Dayyeh, B. K., Eaton, L., Robinson, J., Woodman, G., Fusco, M., Shayani, V, Billy, H., Pambianco, D., & Gostout, C. (2017) · International Journal of Obesity · doi:10.1038/ijo.2016.229 · Cited by 167
A history of intragastric balloons
Gleysteen, J. J. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2015.10.074 · Cited by 113
“Other authors proclaim the safety of the technique along with highly favorable (73%) treatment satisfaction and high resolution of obesitymetabolic symptoms [20].”
BackgroundPopov, V. B., Ou, A., Schulman, A. R., & Thompson, C. C. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.530 · Cited by 100
Kumar, N., Bazerbachi, F., Rustagi, T., McCarty, T. R., Thompson, C. C., Galvao Neto, M. P., Zundel, N., Wilson, E. B., Gostout, C. J., & Abu Dayyeh, B. K. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2636-3 · Cited by 81
Metadata
- Authors
- Fuller, N. R., Pearson, S., Lau, N. S., Wlodarczyk, J., Halstead, M. B., Tee, H., Chettiar, R., & Kaffes, A. J.
- Venue
- Obesity
- Publisher
- Wiley
- Published
- 2013-06-11
- Volume
- 21
- Issue
- 8
- Pages
- 1561-1570
- ISSN
- 1930-7381 (ISSN-L)
- 1930-739X
- OpenAlex
- W1649724460
- Cited by
- 107
- References
- 12
- FWCI
- 6.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.